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Abstract
Background: Various endometrial abnormalities have been associated with luteal phase deficiency: a significant
dyssynchrony in the maturation of the glandular epithelium and the stroma and a prevalence of out-of-phase
endometrial biopsy specimens. Out-of phase endometrium is a controversial disorder related to failed implantation,
infertility and early pregnancy loss. Given that the regulation of the apoptotic process in endometrium of luteal
phase deficiency is still unknown, the aim of this study was to evaluate cell proliferation, apoptosis and the levels
of the main effector caspase, caspase-3 in the luteal in-phase and out-of-phase endometrium.
Methods: Thirty-seven endometrial samples from sterile or recurrent abortion patients were included in this study:
21 in-phase samples (controls) and 16 samples with out-of-phase endometrium. Biopsy specimens of eutopic
endometrium were obtained from all subjects during days 21-25 of the menstrual cycle. The endometrium with
endometrial maturity of cycle day 25 or less at the time of menstruation was considered out-of phase. Endometrial
tissues were fixed in 10% buffered formaldehyde. For apoptosis quantification, sections were processed for in situ
immunohistochemical localization of nuclei exhibiting DNA fragmentation, by the terminal deoxynucleotidyl
transferase (TdT)-mediated dUTP digoxygenin nick-end labeling (TUNEL) technique. Expressions of Proliferating Cell
Nuclear Antigen (PCNA) as a marker of cell proliferation, and of cleaved caspase-3 as a marker of apoptosis, were
assessed by immunohistochemistry in the luteal in-phase and out-of-phase endometrium from infertile and
recurrent abortion patients.
Results: Luteal out-of-phase endometrium had increased apoptosis levels compared to in-phase endometrium
(p < 0.05). Caspase-3 evaluation confirmed these results: the luteal out-of-phase endometrium showed augmented
cleaved caspase-3 expression (p < 0.005). As well, our data demonstrated that the luteal out-of-phase endometrium
expresses decreased PCNA levels (p < 0.05), showing that cell proliferation is diminished in this tissue.
Conclusions: this study represents the first report describing variations at the cell proliferation and cell death levels
in the out-of-phase endometrium in comparison with in-phase endometrium from infertile and recurrent abortion
patients. Further studies are needed to elucidate a potential role of these alterations in the physiopathology of
luteal phase deficiency.
Background
Endometrial remodelling occurs during each menstrual
cycle in women. The secretory activity in the second
half of the menstrual cycle is characterized by a diversity
of structural changes, showing a different pattern
throughout the cycle [1]. During the luteal phase, the
endometrium is under direct stimulation by progester-
one (P). A rapid decline in P or an inadequate P con-
centration during this period results in a degenerative
endometrium, which is not receptive for implantation of
a fertilized ovum or maintenance of early pregnancy [2].
Luteal phase defect (LPD) is a controversial syndrome
believed to be related to failed implantation, infertility
and early pregnancy loss [3-6]. The physiopathology of
LPD involves disorders such as a luteal phase of less
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than 10 days, abnormal luteinization that causes a
decrease in androstenedione and abnormal follicular
development [7,8]. In stimulated in vitro fertilization
(IVF) cycles, the main cause of the LPD has been related
to the multifollicular development achieved during ovar-
ian stimulation [9].
Various endometrial abnormalities have been asso-
ciated with LPD: a significant dyssynchrony in the
maturation of the glandular epithelium and the stroma
and a prevalence of out-of-phase endometrial biopsy
specimens [1]. However, it is difficult to establish the
exact incidence of out-of phase endometrium and of
LPD because the assessment of histological dating is fre-
quently subjective and lacks precision [10-12].
For many years, endometrial dating was an accepted
assay of the quality of luteal function and a diagnostic
test for LPD. However, recently, the accuracy and repro-
ducibility of endometrial dating have been challenged
[4]. Indeed, the diagnosis of LPD in the clinical setting
remains problematic and controversial primarily because
there is no practical diagnostic method that has been
unquestionably validated.
Out-of-phase endometrium is an aberration that is
often found in infertile patients. Even if it is well known
that abnormal endometrium is an important cause to
recurrent miscarriage, Peters et al. found no significant
differences between fertile, infertile and recurrent preg-
nancy loss patients with in- and out-of-phase endome-
trium [13]. At present, the origin of out-of-phase
remains controversial.
Apoptosis, or programmed cell death, plays an impor-
tant role in the cyclic changes that take place during the
menstrual cycle. This mechanism is coded genetically
and contributes to the homeostasis of the tissues. Sev-
eral investigations have revealed that uterine endome-
trium can be regulated by apoptosis [14-16]. In the
human endometrium, there had been shown changes in
apoptosis of the glandular epithelium throughout the
menstrual cycle [17,18]. Recent publications confirmed
the presence of endometrial apoptosis, mainly in the
late secretory phase of the menstrual cycle [14,15].
Apoptosis is an important mechanism in the regula-
tion of the endometrial growth both in the physiology
and in the pathology. Previous work from our group,
showed an increased survival capability in the eutopic
endometrium from patients with endometriosis. This
abnormal survival of endometrial cells may result in
their continuing growth into ectopic locations [19-21].
In addition, it is well known that the regulation of pla-
cental apoptosis is essential for the normal physiology
of pregnancy during implantation since apoptosis is
important for the appropriate tissue remodelling of the
maternal decidua and invasion of the developing
embryo [22].
Given that the regulation of the apoptotic process in
endometrium of LPD is still unknown, the aim of this
study was to evaluate cell proliferation, apoptosis and
the levels of the main effector caspase, caspase-3 in the
luteal in-phase and out-of-phase endometrium.
Methods
Tissue collection
Fifty five endometrial samples were obtained from
patients who attended for sterility or recurrent abortion
at the Sterility Sector of Clinics Hospital from Buenos
Aires. Eighteen samples were excluded as 3 were disso-
ciated endometrium, 10 were proliferative, 3 became
pregnant at that cycle and 2 had endometritis. Overall, a
total of 37 luteal endometrial samples were included in
this study. All patients involved gave informed consent
to participate in the present study, which has approved
by the Hospital and the Institutional Ethics Committees.
The control group consisted of 21 in-phase luteal
endometrium samples and the study group consisted of
16 luteal out-of-phase endometrium samples. Most of
the patients attended for sterility, only 3 patients in the
control group and 2 in the out of phase group attended
for early recurrent abortion. Both groups were similar in
age (33,3 ± 1.0 and 35,3 ± 0.9 years in average respec-
tively). Underlying pathology was discarded in all cases
by histological and clinical studies.
Biopsy specimens of eutopic endometrium were
obtained from all subjects during days 21-25 of the
menstrual cycle using a Novak curette. For endometrial
dating, 4 μm sections stained with hematoxylin and
eosin and periodic acid Schiff stain were evaluated. All
endometrial biopsies were evaluated by the same expert
pathologist according to the histopathological criteria of
Noyes et al [23]. The endometrium with endometrial
maturity of cycle day 25 or less at the time of menstrua-
tion was considered out-of phase. Endometrial tissues
were fixed in 10% buffered formaldehyde.
Apoptosis detection system
For apoptosis quantification, sections were processed for
in situ immunohistochemical localization of nuclei exhi-
biting DNA fragmentation, by the TUNEL technique,
using the apoptosis detection kit Apoptag Plus (Chemi-
con International, Temecula CA, USA). Sections were
treated according to the manufacturer’s instructions as
previously described [19].
Briefly, sections were deparaffinized and rehydrated
with xylene and ethanol, and permeabilized with 20 μg/
ml Proteinase K (Gibco, Grand Island, NY, USA). Endo-
genous peroxidase was inactivated by coating the samples
with 3% H2O2. Sections were rinsed with PBS, and then
immersed 60 min in TdT buffer at 37°C. Afterwards, they
were incubated 30 min with the anti-digoxygenin
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peroxidase conjugate, followed by the peroxidase sub-
strate diaminobenzidine (DAB). Finally, sections were
counterstained with hematoxylin. Sections of female
rodent mammary gland obtained 3-5 days after weaning
of pups, were used as a positive control. As a negative
control, a number of tissue samples were subjected to
treatment without TdT. The percentage of apoptotic
cells was determined by counting labeled cells at 400X
magnification in 10 randomly selected and homogeneous
fields.
Apoptotic cells were also identified by their characteris-
tic morphological features in hematoxylin-eosin-stained
endometrial sections: cell shrinkage and chromatin
margination or chromatin condensation with formation
of apoptotic bodies [19].
The TUNEL method is characterized by higher sensi-
tivity than most other histochemical approaches and is
considered to be the gold standard to detect apoptosis
in situ [24]. However, in order to complete the apopto-
sis evaluation we also included the assessment of the
cleaved caspase-3, the most important effector enzyme
in apoptosis pathway.
Immunohistochemistry
Serial sections of the endometrium were subjected to
standard immunohistochemistry as previously described
[25]. Briefly, sections were deparaffinized in xylene and
rehydrated through graded alcohols followed by micro-
waving in 0.01 M sodium citrate buffer for antigen
retrieval. Endogenous peroxidase was blocked by treat-
ment with 3% hydrogen peroxide for 10 min at room
temperature, after which, non-specific binding was
blocked incubating with 4% bovine serum albumin in
phosphate buffer for 60 min. Tissue sections were incu-
bated overnight with the primary antibody: rabbit anti-
human PCNA polyclonal (FL-261, Santa Cruz Biotech-
nology, Santa Cruz, CA); or rabbit anti-human cleaved
caspase-3 (CP 229, Biocare Medical, Concord, CA) at
4°C. After that, sections were treated for 60 min with a
universal secondary biotinylated antibody followed by
incubation with streptavidin-peroxidase conjugated
(LSAB+ Kit/HRP System, Dako, Carpinteria, CA). Bind-
ing was visualized by incubating sections with DAB and
lightly counterstaining with hematoxylin, prior to per-
manent mounting. As a negative control, species and
class matched igG was used. The negative control
showed absence of specific staining.
PCNA positive cells were identified by the presence of
brown nuclear reactivity in the endometrial epithelial
cells. PCNA, also called cyclin, is a 36-Kd auxiliary pro-
tein of DNA polymerase-delta, which was found to be a
useful marker in immunocytochemical studies of cell
proliferation, because its expression correlates with the
proliferative state of the cell [26]. PCNA is a proliferation
marker for cells in early G1 phase and S phase of the cell
cycle. PCNA immunohistochemistry has been extensively
used for basic research and as a prognostic tool in surgi-
cal pathology [27-29] and has good correlation with
KI-67 [30] expression. It has been shown that immuno-
histochemistry, to detect nuclear antigens such as PCNA
expressed during the cell cycle in proliferating cells, is a
good approach to assess cell proliferation [31].
The number of cells expressing immunoreactivity for
PCNA per 100 cells was established using a standard
light microscope by two independent observers. The
total number of epithelial cells in 10 representative fields
was counted. Any nuclear staining was regarded as posi-
tive. There was no significant difference in results
between the two observers (data not shown).
Cleaved caspase-3 detects endogenous levels of the
large fragment (17/19 kDa) of activated caspase-3 result-
ing from cleavage adjacent to (Asp175). Activation of
caspase-3 requires proteolytic processing of its inactive
zymogen into active p17 and p12 subunits. Staining for
cleaved caspase-3 was assessed to study apoptosis in
endometrial epithelial cells. The percentage of cells
expressing immunoreactivity for cleaved caspase-3 was
established by analyzing 10 representative fields from
each specimen.
Statistics
Statistical analysis of the data was performed using
GraphPad Instat V4.0 software. A non-parametrically
two-tailed Mann-Whitney U-test was used for determi-
nation of differences in the two groups. Results were
expressed as mean ± S.E.M. A value of p < 0.05 was
considered to be significant.
Results
Apoptosis in in-phase and out-of-phase endometrium
The apoptosis detection system revealed positive stain-
ing only in the glandular epithelium of the endometrium
sections. An increased apoptosis was detected in eutopic
out-of-phase endometrium compared to in-phase con-
trols: 57.1 ± 4.1 vs. 37.5 ± 5.6 expressed as percentage
of TUNEL positive cells (p < 0.05, Figure 1B and 1C
and Figure 2).
Immunohistochemistry for cleaved caspase-3 in in-phase
and out-of-phase endometrium
Complementary to the results obtained by the TUNEL
method, the immunohistochemical staining using a spe-
cific antibody for the cleaved fragment of caspase-3
revealed increased immunoreactivity in epithelial endo-
metrial cells from out-of-phase samples compared to in-
phase controls: 49.9 ± 4.2 vs. 23.0 ± 5.82 expressed as
percentage of cleaved caspase-3 positive cells (p < 0.005,
Figure 1E and 1F and Figure 3).
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Cell proliferation in in-phase and out-of-phase
endometrium
The out-of-phase endometrium showed a significantly
decreased degree of cell proliferation in the epithelial
cells in comparison to in-phase controls: 25.7 ± 3.0 vs.
38.9 ± 4.2 expressed as percentage of PCNA positive
cells (p < 0.05, Figure 1H and 1I and Figure 4).
Discussion
Luteal phase defect (LPD) is a controversial entity of
considerable clinical importance that is implicated in
infertility and recurrent spontaneous abortion. A pre-
valence of out-of-phase endometrial biopsy specimens
have been associated with luteal phase deficiency
(LPD) [1]. Luteal phase inadequacy is a subtle disrup-
tion of luteal function and it may be considered the
most common ovulatory disorder in women [32]. It
has also been found that most of women with out-of-
phase midluteal endometrium may have a cryptic form
of LPD [33].
Despite the existence of LPD has been questioned by
some authors [34] and a recent report showed that out-
of-phase biopsy poorly discriminated between women
from fertile and infertile couples in either mid luteal or
late luteal phase [35], there has been abundant clinical
and experimental research establishing the reality and
importance of LPD [4,8,36-38]. Although some authors
prefer to perform evaluation of serum P [39], the diag-
nosis of LPD is best based on a histological study of the
endometrium [11]. The most commonly used method to
assess luteal function in infertility has been the direct
evaluation of endometrial biopsy and histological
Figure 1 Apoptosis, cleaved caspase-3 expression and cell proliferation in in-phase and out-of-phase endometrium. Histological
sections were assessed for apoptosis by TUNEL (A-C) and immunostained for cleaved caspase-3 (D-F) and PCNA (G-I). Negative control sections
were incubated in absence of TdT for apoptosis detection (A) and with an immunoglobulin of the same immunoglobulin class and
concentration as the primary antibody for cleaved caspase-3 (D) and PCNA expression (G). Out-of-phase endometrium shows higher levels of
apoptotic cells (C) and cleaved caspase-3 positive cells (F) and decreased levels of cell proliferation (I) compared to in-phase endometrium (B, E,
and H respectively). Magnification: 400X.
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dating [40]. It was found that an endometrial biopsy
which was well dated showed a definite correlation with
the P assays and could be considered as the most easily
performed and reliable indicator, useful in detecting a
luteal phase defect [41].
In order to identify some endometrial differentiation
patterns between in- and out-of phase-endometrium,
Hirama and Ochiai examined the role of hormone
receptor compartmentalization in infertile women and
found that the level of cytosol estrogen receptor was sig-
nificantly lower in out-of-phase endometrium regardless
of serum P levels [42]. In addition, differences in
integrin expression between in- and out-of-phase endo-
metrium were observed for avb3 integrin [40].
For the purpose of continuing with the identification
of the distinctiveness between in-phase and out-of phase
endometrium, the aim of the present study was to inves-
tigate whether apoptotic endometrial characteristics dif-
fer in samples with or without this abnormality.
Endometrial cell death will be menstrual cycle depen-
dent, and therefore timing of biopsy is crucial. The
endometrial biopsies used in this study were from days
21-25 of the menstrual cycle.
In the present study we found that the out-of-phase
endometrium from infertile and abortion patients had
increased apoptosis levels. In addition, caspase-3 evalua-
tion confirmed these results: the out-of-phase endome-
trium derived from these patients showed augmented
cleaved caspase-3 expression, which indicated caspase-3
activation at the epithelial cells compared to in-phase
endometrium. Furthermore, our data demonstrated that
the out-of-phase endometrium from infertile and abor-
tion patients expresses decreased PCNA levels, showing
that cell proliferation is diminished in this endometrial
tissue.
In this work, we decided to evaluate glandular apopto-
sis of in-phase and out-phase endometrium since it was
reported in several works that endometrial epithelial
glandular cells show the most significant cyclical apop-
totic changes throughout the cycle. Apoptotic cells were
mainly detected in the glandular epithelium of the endo-
metrium and only very few apoptotic cells were detected
in the stroma at any stage of the cycle. The endometrial
cells in the basal layer showed no evidence of apoptosis
throughout the menstrual cycle [43]. In addition, Bcl-2,
Figure 2 Apoptosis in in-phase and out-of-phase endometrium.
Apoptosis was assessed by TUNEL technique in the epithelial
fraction. The percentage of apoptotic cells were determined by
counting labelled cells at 400X magnification in 10 randomly
selected and homogeneous fields. Out-of-phase endometrium
presents a significantly higher percentage of apoptotic cells than in-
phase controls. * p < 0.05 vs. Control.
Figure 3 Cleaved caspase-3 expression in in-phase and out-of-
phase endometrium. Histological sections were immunostained for
cleaved caspase-3 expression (see text). Cleaved caspase-3 detects
endogenous levels of the large fragment (17/19 kDa) of activated
caspase-3. The percentage of cells expressing immunoreactivity for
cleaved caspase-3 was established by analyzing 10 representative
fields from each specimen. Out-of-phase endometrium shows a
significantly higher percentage of cleaved caspase-3 positive cells
than in-phase controls. ** p < 0.005 vs. Control.
Figure 4 Cell proliferation in in-phase and out-of-phase
endometrium. Histological sections were immunostained for PCNA
expression (see text). The total number of epithelial cells in 10
representative fields was counted. Cell proliferation was quantified
in the epithelial fraction as percentage of PCNA positive cells. Out-
of-phase endometrium shows a significantly lower percentage of
PCNA positive cells than in-phase endometrium. * p < 0.05 vs.
Control.
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Fas and FasL were found predominantly in the endome-
trial glandular fraction and changed dramatically during
the menstrual cycle, while in stromal cells these apopto-
sis related proteins showed no expression or not signifi-
cant cyclic changes [16,44,45]. Also, expression of Bax
and Bcl-x was predominantly localized to epithelial cells
of the functionalis layer of the secretory endometrium
and Tao et al. concluded that cyclic changes in endome-
trial growth and regression may be precisely regulated
by shifts in the ratio or balance of Bcl-2 and related pro-
teins in glandular epithelial cells [18]. In addition, it has
been reported that Ki-67, a proliferation marker, is
expressed specifically in glandular epithelial cells [46].
Taken as a whole, we came to the decision that the
proper way of studying the apoptosis status of the endo-
metrium was evaluating the apoptosis rate of the epithe-
lial cells.
Although in the present work the P levels were not
included since the selection criteria of the out-of-phase
endometrium was based on the histological dating, a
direct correlation between the decrease of P levels and
the increase of apoptosis has been demonstrated by
other authors. However, a controversy exists at the
time since some scientists claimed that histological
endometrial dating does not reflect circulating P con-
centrations, and that decreased progesterone receptors
on endometrial gland nucleus results in a deficient
response of endometrium to proper stimulus of pro-
gesterone. It has been reported that LPD is more likely
to be a result of an abnormal response of the endome-
trium to P, than to a subnormal production of P by
the corpus luteum [4,11].
It is well known that endometrial cell proliferation
and cell death are regulated by ovarian hormones. In
the endometrium, the fall of ovarian P in late secretory
phase or the withdrawal of ovarian hormones, are fol-
lowed by apoptosis. Removal of P led to a substantial
increase of endometrial apoptosis, to a significant
induction of the proapoptotic proteins Fas, FasL, BIM
expression and to an increase of the bcl-XS/bcl-XL
ratio [47-49].
Additionally, apoptosis is an important component of
the correct implantation process [22]. Although in the
present paper increased endometrial cell death rates
were observed in out-of-phase endometrium samples, a
direct correlation with spontaneous pregnancy loss or
infertility has not been demonstrated. Nevertheless
abundant data illustrating this association have been
reported in the literature. In pregnancies complicated by
preeclampsia or intrauterine growth restriction, there is
an augmented incidence of placental apoptosis which is
associated with deficient trophoblast invasion [50,51]. In
addition, elevated apoptosis rates were found in abor-
tion-prone mice [52] and a strong increase of Bax
expression was found in the cytotrophoblast, stroma,
endothelial cells and deciduas of placentas of the first
trimester abortion compared to the low/moderate Bax
immunopositivity in all the placental compartments dur-
ing the first trimester after voluntary termination of
pregnancy [53]. FasL and Fas are also elevated in the
endometrium and in endometrial lymphocytes asso-
ciated with abortion in experimentally model of porcine
spontaneous fetal loss [54]. As well, Savion et. al. sug-
gested a possible role for the apoptotic process in
mechanisms mediating pregnancy loss and indicated an
involvement of p53 and bcl-2 in its regulation [55]. All
these data suggest that infertility or recurrent abortion
in LPD patients with out-of-phase endometrium could
be associated to the increased cell death levels observed
in their endometrial samples.
One of the limitations of our study is that there is no
comparison with endometrium from normal fertile
women. However, underlying pathology was discarded
in all cases by histological and clinical studies. Further-
more, the purpose of this study was to address the ques-
tion about differences between in-phase and out-of-
phase endometrium and inclusion of endometrium
samples from normal fertile patients was not essential
for this intention.
Additional evidence is necessary to know if infertility
or recurrent abortion in LPD patients with out-of-phase
endometrium could be associated to the increased cell
death levels observed in their endometrial samples.
Conclusions
In conclusion, this study represents the first report
describing variations at the cell proliferation and cell
death levels in the out-of-phase endometrium from
infertile and abortion patients in comparison with
in-phase endometrium. Further studies are needed to
elucidate a potential role of these alterations in the phy-
siopathology of LPD.
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